A Study to Evaluate the Safety and Tolerability of EXN407

Clinical trial NCT04565756 · COMPLETED

Trial details

NCT number: NCT04565756
Sponsor: Exonate Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2020-11-05
Primary completion: 2022-10-25
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.